Recent data released by the Centers for Disease Control and Prevention (CDC) highlights a worrying trend in West Michigan: an increase in cannabis-related emergency room visits due to Cannabis Hyperemesis Syndrome (CHS). CHS, characterized by severe nausea and vomiting, is an ailment linked to chronic cannabis use. Local dispensaries like Indigrow in Muskegon are responding by informing customers about potential risks associated with THC consumption. This rise in ER visits underscores the need for stronger public health efforts and better regulation of cannabis products. The new diagnosis code implemented by the CDC aims to improve the tracking and management of CHS cases. As more cases emerge, healthcare providers in West Michigan are called to enhance awareness and detection of this syndrome, which is still unfamiliar to many despite its significant impact.
WWMTNew data shows Blue (BRBS) stock dip post quarterly earnings release
Blue (BRBS) recently disclosed its quarterly earnings, revealing significant insights into the company’s financial health. While initial data indicated promising performance, the stock saw a